Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 734,057 | $90,098,190 | +10% | 1.99% |
| 2. | Impax Asset Management Ian Simm | 296,565 | $36,400,388 | +8% | 0.23% |
| 3. | Polaris Capital Management Bernard Horn | 265,100 | $32,538,374 | -16% | 2.7% |
| 4. | Lee Munder Capital Group Lee Munder | 17,604 | $2,160,715 | -1% | 0.12% |
| 5. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 9,488 | $1,164,557 | -4% | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $140.24 | 4,968 | $696,725.24 | 556,698 | 2026-01-28 | Filing | |
| $139.54 | 5,032 | $702,185.91 | 561,666 | 2026-01-28 | Filing | |
| $135.00 | 115,640 | $15,611,400.00 | 566,698 | 2026-01-23 | Filing | |
| $123.50 | 5,000 | $617,500.00 | 8,920 | 2026-01-20 | Filing | |
| $124.31 | 3,000 | $372,930.00 | 150,503 | 2026-01-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 121,097,336 | $14,863,487,020 | 0.22% | |
| 2. | 5,138,699 | $630,055,884 | 0.54% | |
| 3. | 4,779,679 | $586,657,800 | 0.1% | |
| 4. | 4,223,304 | $518,368,332 | 0.17% | |
| 5. | 3,693,602 | $453,352,712 | 0.65% |
News See All
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating
Gilead Sciences, Inc. (NASDAQ:GILD) is among the 12 Most Profitable NASDAQ Stocks to Buy Right Now.
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price target on Gilead Sciences, Inc.
12 Most Profitable NASDAQ Stocks to Buy Right Now
2025 was another stellar year for the markets, marking the third successive instance of double-digit returns for the indices.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
UBS and Citi Go Bullish on Gilead Sciences (GILD)
On January 7, 2026, reports highlighted that analysts are increasingly confident in Gilead Sciences, Inc.
11 Most Undervalued Blue Chip Stocks to Buy Now
As we enter 2026, U.S. equities are expected to enter a phase marked by several complexities following the outsized gains in 2025.
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade.
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans.
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
